The Immunology of Hormone Receptor Positive Breast Cancer

Immune checkpoint blockade (ICB) has revolutionized the treatment of cancer patients. The main focus of ICB has been on reinvigorating the adaptive immune response, namely, activating cytotoxic T cells. ICB has demonstrated only modest benefit against advanced breast cancer, as breast tumors typical...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldberg, Jonathan, Pastorello, Ricardo G., Vallius, Tuulia, Davis, Janae, Cui, Yvonne Xiaoyong, Agudo, Judith, Waks, Adrienne G., Keenan, Tanya, McAllister, Sandra S., Tolaney, Sara M., Mittendorf, Elizabeth A., Guerriero, Jennifer L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202289/
https://www.ncbi.nlm.nih.gov/pubmed/34135901
http://dx.doi.org/10.3389/fimmu.2021.674192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202289/
https://www.ncbi.nlm.nih.gov/pubmed/34135901
http://dx.doi.org/10.3389/fimmu.2021.674192

Ejemplares similares